(lp0
S'PSivida Corp.  Receives An Update From Brokers The De Soto Edge - Jan 17, 2017 12/05/2016 - pSivida Corp. had its  rating reiterated by analysts at FBR Capital Markets. They now have a USD 7 price target on the stock.'
p1
aS'PSivida Redux: Multiple Opportunities For Value Creation Seeking Alpha - Oct 4, 2016 In a prior article I presented the case that the market potential for Medidur in Posterior Uveitis was likely to be small. In addition to Medidur, pSidiva has diversified assets that includes royalty streams on marketed products and platform ...'
p2
aS"pSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results GlobeNewswire  - Feb 7, 2017 WATERTOWN, Mass., Feb. 07, 2017  -- pSivida Corp.  , a leader in the development of sustained release drug products and technologies, today reported financial results for its fiscal 2017 second quarter and&nbsp;...pSivida's  CEO Nancy Lurker on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha"
p3
aS"Topline Results from First Phase 3 Trial of pSivida's Medidur Presented at ... GlobeNewswire  - Aug 15, 2016 WATERTOWN, Mass., Aug. 15, 2016  -- pSivida Corp.  , a leader in the development of sustained release drug delivery products primarily for eye diseases, announced that Dr."
p4
aS"pSivida Corp. PSDV  Wall Street Journal - Feb 11, 2011 News pSivida Corp.PSDV. Significant News Only. 03/15/17; Press Release. Abstract on pSivida's Treatment of Posterior Segment Uveitis Accepted for Presentation at the 2017 Association for Research in Vision and Ophthalmology  Annual Meeting."
p5
aS'PSivida - A Growth Biotech Company With Approaching Catalysts Seeking Alpha - Dec 4, 2015 PSivida  is a microcap biotechnology company, specialized in the development of sustained release drug delivery products.'
p6
aS'pSivida Corp. Announces Plan to Consolidate all Research and Development in ... GlobeNewswire  - Jul 15, 2016 WATERTOWN, Mass., July 15, 2016  -- pSivida Corp  , a leader in the development of sustained release drug delivery products primarily for eye diseases, announced today that it is implementing a site&nbsp;...'
p7
aS'PSivida: Caveat Emptor On Medidur Potential Seeking Alpha - Sep 12, 2016 PSivida is developing Medidur as an intravitreal injectable treatment for chronic, noninfective Posterior Uveitis patients.'
p8
aS'pSivida Implements Leadership Change -- Nancy Lurker Named as President and CEO GlobeNewswire  - Sep 15, 2016 WATERTOWN, Mass., Sept. 15, 2016  -- pSivida Corp.  , a leader in the development of sustained release drug delivery products primarily for eye diseases, announced that its Board of Directors has&nbsp;...'
p9
aS"A Closer Look At PSivida's Pipeline Seeking Alpha - Sep 16, 2013  Iluvien is pSivida's  most advanced stage product and is partnered with Alimera Sciences . Iluvien has a PDUFA&nbsp;..."
p10
a.